Results 201 to 210 of about 53,118 (291)

Induction of proximal tubular proliferation and lengthening in response to sodium glucose linked cotransporter‐2 inhibition in experimental rats

open access: yesJournal of Diabetes Investigation, EarlyView.
While SGLT2 accounts for >90% of kidney glucose reabsorption, its pharmacological inhibition or genetic knockdown reduces glucose reabsorption by only 50%. We found that the SGLT2 inhibitor, dapagliflozin, induced an early, transient hyperplastic response in the SGLT1‐expressing S3 segment of the proximal tubule followed by an increase in its length ...
Ellen Wu   +14 more
wiley   +1 more source

Podocyte-specific KLF6 primes proximal tubule CaMK1D signaling to attenuate diabetic kidney disease. [PDF]

open access: yesNat Commun
Gujarati NA   +8 more
europepmc   +1 more source

Human Bence Jones protein toxicity in rat proximal tubule epithelium in vivo

open access: bronze, 1987
Paul W. Sanders   +4 more
openalex   +1 more source

Canagliflozin protects cardiovascular function in type 2 diabetic coronary artery disease by regulating natriuretic peptide B

open access: yesJournal of Diabetes Investigation, EarlyView.
Canagliflozin regulated the cyclic guanosine monophosphate (cGMP)‐protein kinase 1‐α signaling pathway through the natriuretic peptide B gene, thereby improving cell viability, apoptosis, and reactive oxygen species levels, and ultimately protecting cardiac function in type 2 diabetic patients with coronary artery disease.
Jiarui Zhang   +5 more
wiley   +1 more source

Urinary and Serum Amino Acids May Be Associated with Podocyte, Proximal Tubule, and Renal Endothelial Injury in Early Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients. [PDF]

open access: yesBiomedicines
Mogos M   +15 more
europepmc   +1 more source

1600 METABOLIC CHANGES IN ENRICHED PROXIMAL TUBULES AFTER ISCHEMIC INJURY [PDF]

open access: bronze, 1985
Karen H Gaudio   +5 more
openalex   +1 more source

Clinical use and monitoring of adverse effects of sodium‐glucose cotransporter‐2 inhibitors in persons with type 1 diabetes mellitus

open access: yesJournal of Diabetes Investigation, EarlyView.
Multiple regression analysis revealed that diuretic use was an independent risk factor for discontinuation of SGLT2i. ABSTRACT Aims This study aimed to evaluate the factors contributing to insulin dosage adjustment and the risk of sodium‐glucose cotransporter‐2 inhibitor (SGLT2i) discontinuation in persons with type 1 diabetes mellitus (T1DM) starting ...
Chinatsu Sakai   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy